7 Best Prior Authorization Software Systems 2026

Prior authorization software is the workflow that asks a payer whether a drug, procedure, or service may be delivered before you deliver it — and then files the evidence when the answer is no. It is not the EHR, and it is not the whole RCM stack. It is the queue that burns staff time while the patient waits.

Physician burnout (2024): 43.2% according to the American Medical Association (2025), down from 48.2% in 2023 and 53% in 2022. Prior auth is not the only driver, but it is one of the administrative jobs those surveys keep naming. Use the current 43.2% figure, not the older 53% headline.

A Step-by-Step Buying Recipe

1. List the payers that generate 80% of your auth volume. If they already sit in an EHR-native portal, you may not need a seventh vendor.

2. Split pharmacy (CoverMyMeds / Surescripts neighborhood) from medical (Waystar, Cohere, Rhyme, Infinx).

3. Ask whether you need electronic prior auth (ePA) submission, status, or full clinical documentation attachment.

4. Demand a written price. None of the seven published a self-serve matrix we could verify on 2026-09-04.

5. Test the export: can a human download a status file if the vendor relationship ends?

6. Only then book two demos in the same lane.

TL;DR: Surescripts/CoverMyMeds is the pharmacy ePA network most clinics already touch. Waystar is the RCM vendor that also sells prior auth inside financial clearance. Cohere, Rhyme, and Infinx are utilization-management and intake specialists. Honey Health is an AI-ops newcomer. Optum is the conglomerate option if Optum is already in the building. All seven are quote-led.

Key Takeaways

• Pharmacy ePA and medical prior auth are different products. Do not score them as one grid.

• Waystar's public RCM story includes automating prior authorizations inside financial clearance, with 1 million+ providers according to Waystar (2026) as a vendor claim — still no public price.

• KLAS 2026 added a prior-authorization category and did not award Best in KLAS in it, according to TechTarget (2026). There is no clean "KLAS winner" to hide behind.

• EHR-native auth (Epic CRD-style coverage checks at health systems) can make a standalone tool redundant. We could not retrieve the HealthCare Dive article named in the brief (paywall), so we do not treat that launch as independently verified here.

• Prior-auth software queues work; it does not automatically appeal, schedule, or collect.

On 12,514 pages counted 2026-08-24, healthcare page earn rate: 8.7% according to US Tech Automations first-party mix-config (2026).

'7 Best' title earn rate: 25.5% vs 14.0% according to US Tech Automations Phase 1 count (2026).

How We Weighted the Criteria

Verified Pricing, September 2026

Waystar patient-access KLAS score: 91.2 according to TechTarget's KLAS 2026 write-up (2026). That award is patient access, not a dedicated prior-auth Best in KLAS (the new category had no award).

Feature Coverage, Normalized

The Seven Platforms

Surescripts — best as the pharmacy ePA network you probably already use

Best fit: clinics whose prior-auth pain is drugs, not surgeries, and who need a network that pharmacies and EHRs already know. CoverMyMeds sits in this neighborhood; buy the network, not a second EHR.

Limitations: unpublished price. Medical-benefit auth for procedures is a different shortlist. If your bottleneck is spinal fusion, this is the wrong demo.

Cohere Health — best for medical utilization management programs

Best fit: health systems and plans running structured medical UM, often with clinical criteria and nurse review, not a three-person clinic buying a portal login.

Limitations: quote-only. Overkill if you only need pharmacy ePA. Confirm whether you are the provider or the plan in the contract.

Infinx — best when prior auth is bundled with patient access

Best fit: groups that want eligibility, auth, and medical records retrieval in one access vendor rather than a pure UM network.

Limitations: unpublished price. Confirm which module you are actually buying. Access vendors sell stacks; RFPs that say "prior auth" still get a bundle.

Rhyme — best when the pitch is collaborative, multi-party auth

Best fit: organizations that want providers and payers on one auth workflow instead of portal-hopping.

Limitations: unpublished price. Independent clinics should ask whether their top payers are actually on the network before signing.

Waystar — best when prior auth is part of a broader RCM buy

Best fit: providers already evaluating Waystar for claims, eligibility, and patient pay who want auth in the same financial-clearance lane. Homepage copy lists "automate prior authorizations" under Financial Clearance.

Limitations: you may be buying a platform, not a point tool. No public price. KLAS did not hand a 2026 Best in KLAS to a prior-auth category winner.

Honey Health — best as an AI-ops experiment with a human owner

Best fit: groups willing to trial AI document and inbox work with a named clinician reviewer. Treat it as an automation layer, not as a Surescripts replacement.

Limitations: unpublished price, thinner public proof than Waystar or Surescripts. Do not switch the pharmacy network to chase a demo.

Optum — best when Optum is already the political answer

Best fit: organizations whose payer mix, analytics, or existing Optum services make a second UM vendor expensive to explain.

Limitations: unpublished price, conglomerate sales motion, wrong buy for a clinic that just needs CoverMyMeds working in the EHR.

A Worked Example: Where Prior-Auth Software Stops

A 6-provider specialty clinic submitting 220 medical auths a month, 40% approved same week, 35% pended for records, 25% denied (55 denials). The auth tool submits CoverageEligibilityRequest.purpose (FHIR) or the vendor's equivalent and stores the decision. The leak is the pended 77 files that still need a PDF from the EHR, plus the 55 denials that need an appeal calendar. When a payer posts an approval, scheduling still has to create the slot and the RCM still has to know the visit is billable. A 5% missed-handoff rate is about 11 visits a month that were approved and never booked. That is not Surescripts' defect. A proposed US Tech Automations workflow could watch the auth-status webhook, drop the chart PDF, open the slot, and escalate denials — API access and a human review before any appeal ships, not a live deployment.

Who This Is For

Medical groups, specialty clinics, and health-system access teams whose staff live in payer portals. Pure dental offices and cash-pay practices should skip this list.

Red flags: Do not add a seventh vendor if the EHR already submits ePA for your top payers. Do not buy a medical UM platform to fix pharmacy ePA. Do not sign if nobody owns payer-rule maintenance.

Related reading on other systems of record: field service management, invoicing, applicant tracking.

Build vs Buy: The Honest Alternative

Zapier, Make, or n8n can move "approved" from an auth portal to a schedule with retries and logs. You still own HIPAA, access, idempotency (one approval must not book twice), and retention. US Tech Automations would add a durable pended-file queue and a required human click before an appeal leaves. If volume is 20 auths a month, a biller plus CoverMyMeds is enough.

When NOT to use US Tech Automations

If the EHR's ePA already returns status and your staff is not rekeying, stop. If Waystar financial clearance already includes the auth module you use, do not bolt a second brain on it. If you are cash-pay, you do not have this problem.

Common Buying Mistakes

Payer Turn-Up Is the Real Implementation

Prior-auth software does not "go live" when the SSO works. It goes live when your top 10 payers accept electronic packets with the attachments they actually want. Budget a payer-by-payer calendar: eligibility first, then submission, then status webhooks, then denial codes you can route. A clinic that turns up two payers and declares victory will still live in the other portals.

Pharmacy ePA through Surescripts/CoverMyMeds is often already in the EHR. The expensive duplicate is buying a medical UM platform and then still opening CoverMyMeds for drugs. Keep the lanes split in the contract: which NPI, which tax ID, which payer list, which benefit type.

Medical UM vendors will demo a beautiful collaborative inbox. Ask for the list of health plans that posted a decision into that inbox last month for a group your size. If the answer is a roadmap, you are buying a portal with extra steps.

Health-system EHR-native coverage checks (Epic CRD-style) can make a standalone tool look redundant for employed physicians. Independent groups do not get that for free. Ask the EHR vendor what is live for your payers, not what was announced at a health-system conference. We could not verify the HealthCare Dive hospital list (paywall), so do not treat that announcement as your go-live plan.

Appeals are where tools quietly stop. An "denied" status without a due date, a packet checklist, and an owner is a dashboard. If 55 denials a month is your volume, the orchestration job is the calendar, not another submission UI.

Staff time still dominates. AMA's 43.2% burnout figure is not a prior-auth KPI, but it is why "the nurses will just click through the new tool" is a fantasy. Name a coordinator. If you cannot, keep the EHR ePA and stop shopping.

Write the RFP as three attachments, not one. Attachment A is the payer list with volume. Attachment B is the EHR and clearinghouse you will not rip out. Attachment C is the human path when the tool returns pended: who pulls the PDF, who calls the plan, who books the slot. Vendors that cannot map those three will still sell you a dashboard.

Independent clinics should insist on a 90-day unwind: export of every open auth, status, and attachment. If the contract is silent, you are renting a queue you cannot leave. Health systems should insist on FHIR-friendly status (CoverageEligibilityRequest / ClaimResponse) even if today's connector is a vendor API, because CMS-era prior-auth APIs are the direction of the rails.

Do not let a sales engineer score "AI" as a substitute for payer coverage. Honey Health can be a useful inbox layer with a named reviewer. It is not Surescripts. Optum can be the political answer. It is not CoverMyMeds. Waystar can be the RCM bundle. It is not a reason to skip the pharmacy network you already have.

If 220 auths a month is real, measure time-to-decision and missed-handoffs for 30 days before you sign. If you cannot measure them, you cannot tell whether the new tool worked. Write those two numbers on the first page of the RFP.

Frequently Asked Questions

What is the best prior authorization software?

Pharmacy: Surescripts/CoverMyMeds neighborhood. Medical: Cohere, Rhyme, Infinx, or Waystar if RCM is the buy. There is no single winner across lanes.

Is CoverMyMeds the same as Surescripts?

They sit in the same pharmacy ePA story. Confirm which contract, which EHR connection, and which payers you are actually turning up.

Does Waystar do prior authorization?

Waystar's financial-clearance product page lists automating prior authorizations. That is a module inside an RCM platform, not a reason to ignore pharmacy networks.

Why didn't KLAS pick a Best in KLAS prior-auth vendor in 2026?

TechTarget's report on the 2026 awards says KLAS added the category and did not award it that year. Treat any "KLAS #1 prior auth" claim with suspicion.

How does Epic coverage-requirement discovery change this buy?

Health-system EHR-native checks can reduce standalone tools. The HealthCare Dive piece in our brief was paywalled, so we are not reprinting its hospital list. Ask your EHR vendor what is live for your payers.

Can Zapier replace prior-auth software?

It can copy status. It cannot be the payer network. Keep ePA; automate the handoff to scheduling and appeals.

Glossary

Prior authorization: Payer permission required before a service or drug.

ePA: Electronic prior authorization, usually pharmacy.

UM: Utilization management, medical-benefit review.

FHIR: HL7 standard; CoverageEligibilityRequest is a real resource used in eligibility/auth APIs.

Pended: Auth waiting on records or criteria.

Medical vs pharmacy benefit: Procedure/facility vs drug — different rails.

Financial clearance: Front-end RCM (eligibility, auth, estimates).

Appeal: The follow-up when the payer says no.

Choosing With Confidence

Split pharmacy from medical, then demand a price and a payer list. If the remaining pain is the handoff to the schedule and the appeal calendar, that is orchestration, not a new network.

US Tech Automations can scope that handoff; see pricing.